ASX - By Stock
|
PAB |
Re:
Ann: Positive preclinical data for deoxymabs in vasculitis
|
|
Mickyk
|
60 |
22K |
2 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
60
|
22K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Positive preclinical data for deoxymabs in vasculitis
|
|
Mickyk
|
60 |
22K |
1 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
60
|
22K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Positive preclinical data for deoxymabs in vasculitis
|
|
Mickyk
|
60 |
22K |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
60
|
22K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Positive preclinical data for deoxymabs in vasculitis
|
|
Mickyk
|
60 |
22K |
4 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
60
|
22K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Expanded collaboration with Siemens Healthineers to US
|
|
Mickyk
|
194 |
63K |
1 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
194
|
63K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Application for quotation of securities - PAB
|
|
Mickyk
|
24 |
5.5K |
1 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
24
|
5.5K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Non-renounceable Entitlement Offer Shortfall
|
|
Mickyk
|
15 |
5.8K |
8 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
15
|
5.8K
|
8
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
Mickyk
|
348 |
130K |
2 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
348
|
130K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
Mickyk
|
348 |
130K |
3 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
348
|
130K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Updated guidance for PAT-DX1 phase 1 clinical study
|
|
Mickyk
|
125 |
47K |
1 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
125
|
47K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Company Update - Phase 1 Study Independent Review
|
|
Mickyk
|
186 |
55K |
0 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
186
|
55K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Company Update - Phase 1 Study Independent Review
|
|
Mickyk
|
186 |
55K |
0 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
186
|
55K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Company Update - Phase 1 Study Independent Review
|
|
Mickyk
|
186 |
55K |
2 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
186
|
55K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Company Update - Phase 1 Study Independent Review
|
|
Mickyk
|
186 |
55K |
1 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
186
|
55K
|
1
|
|
ASX - By Stock
|
IBX |
@ImagionBio
|
|
Mickyk
|
1 |
649 |
5 |
28/01/23 |
28/01/23 |
ASX - By Stock
|
1
|
649
|
5
|
|
ASX - By Stock
|
IBX |
Re:
BOB NEEDS TO GO!
|
|
Mickyk
|
62 |
21K |
3 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
62
|
21K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
Mickyk
|
348 |
130K |
0 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
348
|
130K
|
0
|
|
ASX - By Stock
|
MRD |
Re:
Ann: AFR Presentation
|
|
Mickyk
|
25 |
7.6K |
0 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
25
|
7.6K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Abysmal shareholder communication
|
|
Mickyk
|
78 |
28K |
6 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
78
|
28K
|
6
|
|
ASX - By Stock
|
PAB |
Re:
Short term future of PAB
|
|
Mickyk
|
83 |
38K |
3 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
83
|
38K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Short term future of PAB
|
|
Mickyk
|
83 |
38K |
1 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
83
|
38K
|
1
|
|
ASX - By Stock
|
MRD |
Re:
Drilling Results
|
|
Mickyk
|
21 |
7.8K |
4 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
21
|
7.8K
|
4
|
|
ASX - By Stock
|
MRD |
Re:
Drilling Results
|
|
Mickyk
|
21 |
7.8K |
2 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
21
|
7.8K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Short term future of PAB
|
|
Mickyk
|
83 |
38K |
1 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
83
|
38K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Investor presentation
|
|
Mickyk
|
11 |
4.4K |
3 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
11
|
4.4K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
Mickyk
|
605 |
230K |
3 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
605
|
230K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Short term future of PAB
|
|
Mickyk
|
83 |
38K |
0 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
83
|
38K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
Mickyk
|
605 |
230K |
0 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
605
|
230K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1/Radiation Combination Improves Brain Cancer Survival
|
|
Mickyk
|
25 |
10K |
4 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
25
|
10K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
Mickyk
|
5.5K |
1.9M |
3 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
5.5K
|
1.9M
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis
|
|
Mickyk
|
125 |
43K |
1 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
125
|
43K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis
|
|
Mickyk
|
125 |
43K |
0 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
125
|
43K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis
|
|
Mickyk
|
125 |
43K |
2 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
125
|
43K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Stable Cell Line for Production of PAT-DX3 Established
|
|
Mickyk
|
116 |
44K |
3 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
116
|
44K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Stable Cell Line for Production of PAT-DX3 Established
|
|
Mickyk
|
116 |
44K |
0 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
116
|
44K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Stable Cell Line for Production of PAT-DX3 Established
|
|
Mickyk
|
116 |
44K |
0 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
116
|
44K
|
0
|
|
ASX - By Stock
|
MAN |
Re:
Ann: Strong Conductor Identified by Downhole EM
|
|
Mickyk
|
21 |
7.2K |
3 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
21
|
7.2K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human Study Progress Update
|
|
Mickyk
|
195 |
80K |
2 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
195
|
80K
|
2
|
|
ASX - By Stock
|
MAN |
Re:
Ann: Strong Conductor Identified by Downhole EM
|
|
Mickyk
|
21 |
7.2K |
0 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
21
|
7.2K
|
0
|
|
ASX - By Stock
|
MAN |
Re:
Ann: Trading Halt
|
|
Mickyk
|
34 |
10K |
1 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
34
|
10K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 engineering update
|
|
Mickyk
|
176 |
58K |
3 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
176
|
58K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
PAB - A new day is dawning ‘2022’
|
|
Mickyk
|
124 |
40K |
0 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
124
|
40K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
PAB - A new day is dawning ‘2022’
|
|
Mickyk
|
124 |
40K |
2 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
124
|
40K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
PAB - A new day is dawning ‘2022’
|
|
Mickyk
|
124 |
40K |
1 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
124
|
40K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Response to ASX Price Query
|
|
Mickyk
|
122 |
34K |
0 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
122
|
34K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
Mickyk
|
5.5K |
1.9M |
1 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
Mickyk
|
5.5K |
1.9M |
0 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
Mickyk
|
5.5K |
1.9M |
0 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
Mickyk
|
5.5K |
1.9M |
1 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
Mickyk
|
5.5K |
1.9M |
0 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
0
|
|